Introduction
============

Regulatory motifs that allow fine-tuning of gene expression are of interest in the malaria parasite *Plasmodium falciparum*. These include promoters, mRNA stability motifs and translation regulatory sequences. Some regulatory motifs also encode non-coding RNAs (ncRNAs) that in turn regulate expression of genes. The importance of regulatory motifs cannot be underestimated in the parasite since mechanisms of regulation of gene expression are still being elucidated in this human pathogen.[@b1-ebo-7-2011-235]--[@b3-ebo-7-2011-235] The comparative genomics approach has been successfully employed to identify evolutionarily well-conserved regulatory elements in *C. elegans, S. cerevisiae* and *Homo sapiens*.[@b4-ebo-7-2011-235]--[@b6-ebo-7-2011-235] This is based on the rationale that functionally important sequences are often conserved among species. Comparative genomics has also been used in *Plasmodium* species to identify regulatory motifs.[@b7-ebo-7-2011-235]

Another feature of the *Plasmodium falciparum* genome that has proved useful in the search for new regulatory elements has been nucleotide bias. *Plasmodium falciparum* has an unusually AT-rich genome,[@b8-ebo-7-2011-235] with an average AT content of 80% that increases to 90% in intergenic regions. In such a biased genome, local regions of increased GC content in the non-coding regions appear to correlate with functionally important features. For example, a conserved, GC-rich region found upstream of heat shock protein (*hsp*) genes is a functionally important DNA regulatory element.[@b9-ebo-7-2011-235],[@b10-ebo-7-2011-235] In two reports including one from our group, noncoding RNAs (ncRNAs) were identified in *Plasmodium falciparum* based on searching for conserved GC-rich intergenic regions.[@b10-ebo-7-2011-235],[@b11-ebo-7-2011-235] Similarly, nucleotide compositional contrast has been used to identify ncRNA in the AT rich genome of *Dictyostelium discoideum* and hyperthermophiles.[@b12-ebo-7-2011-235]--[@b14-ebo-7-2011-235] This type of screen exploited the fact that most RNA regulatory elements carry out their functions by inter-molecular or intra-molecular base pairing; hence an increase in GC content especially in an AT-rich genome would result in RNAs having more stable secondary structures. [@b15-ebo-7-2011-235] Most of these reports also used comparative genomics and evolutionary conservation as a tool to assess functional significance.

The choice of genomes used for comparative genomics is critical. In a bioinformatics screen described previously,[@b11-ebo-7-2011-235] since the complete genome of *P. yoelii* was available we chose this species for identifying conserved, GC-rich intergenic regions that were shown to encode ncRNAs. However, with the recent availability of other *Plasmodium* genomes, it is likely that other genomes might be equally useful for comparative genomics. Indeed, *P. yoelii* and *P. falciparum* appear to have diverged \>100 million years ago[@b16-ebo-7-2011-235] however, *P. falciparum* has been shown to be most closely related to the chimpanzee malaria parasite *P. reichenowi*.[@b17-ebo-7-2011-235]--[@b19-ebo-7-2011-235] Apart from housekeeping genes, several ORFs that encode cell surface proteins in *P. falciparum* are conserved between *P. falciparum* and *P. reichenowi*; these include CSP,[@b20-ebo-7-2011-235] MSP2[@b21-ebo-7-2011-235] and var CSA.[@b22-ebo-7-2011-235] In contrast, the *var*, *rifin* and *stevor* multigene families that are involved in antigenic variation in *P. falciparum* are represented by a single multi-gene family (*yir*) in *P. yoelii* that is most closely related to the *vir* family in *P. vivax*.[@b23-ebo-7-2011-235],[@b24-ebo-7-2011-235] Over the entire genome, *P. yoelii* is most closely related to the other rodent malaria parasites *P. berghei* and *P. chabaudi*.[@b25-ebo-7-2011-235]

In this report we ask whether regulatory elements can be identified by a bioinformatics screen using elevated GC content in the *P. falciparum* genome, followed by sequence conservation in other *Plasmodium* species. Due to the large evolutionary distance between *P. falciparum* and *P. yoelii*, we hypothesized that the choice of these two genomes for comparative genomics may not identify regulatory elements associated with immunogenic genes that are specifically expressed in *P. falciparum* and not in *P. yoelii*. Hence for identification of genomic sequences that might be involved in host-specific functions eg, evasion from the immune system or regulation of antigenic variation genes, a primate malaria parasite genome would be more appropriate for the comparative genomics part of any bioinformatics screen.

We show that a large number of GC-rich sequences are conserved in the genomes of *P. falciparum* and the primate parasite *P. reichenowi*. Many of these GC-rich sequences flank genes involved in antigenic variation and some may be transcribed and translated. Several reports in the literature show that short RNAs can regulate transcription[@b26-ebo-7-2011-235] and short ORFs can regulate translation of downstream genes.[@b27-ebo-7-2011-235],[@b28-ebo-7-2011-235] Indeed, one of these reports shows that an upstream ORF regulates expression of certain *var* genes.[@b29-ebo-7-2011-235] We suggest that the sequences identified in this study may play roles in regulation of antigenic gene expression at the level of transcriptional or translational control.

Materials and Methods
=====================

GC% filter source data
----------------------

The genome of *Plasmodium falciparum* 3D7 was downloaded chromosome wise from the online database (<http://www.plasmodb.org/>). Exon locations of all protein coding genes were also downloaded from the same database. Due to the unavailability of exon location data in the new version---PlasmoDB 5.2, all the data were downloaded from the older version PlasmoDB 4.4.

GC% C program algorithm
-----------------------

A C program was written which reads large text files of the *Plasmodium falciparum* genome. The program divides the genome into 70 base chunks with the sliding window of 10 bases. It uses exon location data and excludes those chunks which fall within ORFs. The GC% of each chunk was then calculated. An output FASTA file was generated with the sequences of all 70 base chunks with greater than 35% GC according to the sliding window model and lying outside ORFs. If any 70 base chunks with greater than 35% GC were overlapping, these were combined and treated as a single sequence. All such 70 base chunks were associated with their chromosomal locations; note that since overlapping chunks were merged together, some regulatory elements are greater than 70 bases.

Sequence Conservation Source Data
---------------------------------

The genome contigs of *Plasmodium* species *viz. P. yoelii, P. vivax*, *P. reichenowi, P. berghei, P. gallinaceum, P. knowlesi* and *P. chaubadi* were downloaded from PlasmoDB 5.2. The Washington University BLAST version 2.0 (WU-BLAST) downloaded from <http://www.blast.wustl.edu/> was employed to analyze sequence conservation. This BLAST version was installed on a Linux machine.

Shell Script
------------

A shell script was written which took each sequence from the output FASTA file containing sequences having GC content greater than 35% and fed it into the BLAST software. It performs BLAST of all chunks in each of the query files with all the available contigs in the database file. The *E* value cut-off was set as 1e--10.

Positive controls for the above strategy were rRNA, tRNA and the sequences identified with *Plasmodium yoelii* earlier by Upadhyay et al. In short, after running the BLAST analysis of GC-rich sequences using different genomes, we checked whether the 43 annotated tRNAs, 27 annotated rRNAs and 18 ncRNA sequences identified by Upadhyay et al were correctly identified.

Results and Discussion
======================

Use of the *P. reichenowi* genome for comparative genomics can identify novel GC-rich conserved sequences
---------------------------------------------------------------------------------------------------------

Previous work in our lab had used a bioinformatics strategy to identify GC-rich sequences present in intergenic regions that were conserved between *P. falciparum* and *P. yoelii*. This screen used two cut-offs (35% GC followed by an *E* value cut-off of 1e-10) and identified 18 sequences, many of which were found to be small molecular weight RNAs also known as non-coding RNAs (ncRNAs). These cut-offs were appropriate in searching for ncRNAs since we were able to identify all 43 annotated tRNAs and 27 annotated rRNAs from the *P. falciparum* genome.

We hypothesized that using the same strategy but with different genomes for the comparative genomics part of the screen might give more GC-rich, conserved sequences that are associated with host-specific functions. These sequences might be regulatory DNA sequences, ncRNAs or protein-encoding regions. To ensure that the 35% GC cut-off was appropriate for identifying such regulatory sequences, and particularly to be sure that the probability of finding the GC-rich sequence was greater than chance, we did a simple statistical analysis. The average GC content of the 23 megabase *P. falciparum* genome (19%) was compared to the GC content of the 70 base chunks used in the screen (35%) with a Chi-square test using Minitab software. The *P* value of this test was 0.0003, indicating that the probability of finding a 35% GC-rich sequence of 70 bases in the *P. falciparum* genome, is very low. Hence, any GC-rich sequences identified should be significantly different from the genome in their nucleotide content. We proceeded to test our hypothesis that sequences greater than 35% GC-rich and conserved in other *Plasmodium* species might be regulatory sequences associated with host-specific functions.

To test this, we initially performed the bioinformatics screen using only chromosome 1 of *P. falciparum*. This screen retained the original parameters of GC threshold and BLAST cutoff (\>35% GC rich and BLAST value of e-10), however the BLAST analysis was performed against seven *Plasmodium* species---*P. yoelii*, *P. reichenowi*, *P. berghei*, *P. vivax*, *P. gallinaceum*, *P. knowlesi* and *P. chabaudi*. For all genomes except *P. reichenowi*, no new GC-rich, conserved sequences were identified. Interestingly, eighty-five new sequences could be identified when the screen involved comparison with the chimpanzee parasite, *P. reichenowi*. No new sequences were identified when BLAST was performed against the macaque parasite *P. knowlesi* and the human parasite *P. vivax*. This is consistent with reports that *P. knowlesi* falls in the same phylogenetic group as *P. vivax*.[@b19-ebo-7-2011-235] Hence, *P. reichenowi* was chosen as the most appropriate genome to do the comparative analysis for identifying regulatory elements in *P. falciparum.*

Proximal Intergenic Sequences
-----------------------------

The bioinformatics screen was repeated using the entire *P. falciparum* genome to identify GC-rich sequences with a cutoff of 35% GC; these sequences were compared for conservation against the complete *P. reichenowi* genome (BLAST value of e-10) yielding \~1500 conserved GC-rich regions. In order to further prioritize these sequences an additional parameter was applied. This parameter restricted the output to sequences that lie within 500 bases of the start or stop codons of annotated ORFs (termed proximal intergenic regions). The rationale was that a majority of DNA regulatory elements and translational control elements are generally found within 500 bases of the start or stop codons of flanking genes. Hence we decided to sort out sequences that could lie within 5′ or 3′ UTRs of *P. falciparum* genes. Very few *P. falciparum* UTRs have been annotated, nevertheless Watanabe et al conclude from their analysis of a cDNA library that the 5′ UTRs of *P. falciparum* genes are unusually long, averaging 346 bp.[@b30-ebo-7-2011-235] Golightly et al report a 3′ UTR of 450 bp in the mRNA of Pgs28, an ookinete protein of the avian parasite *P. gallinaceum*. [@b31-ebo-7-2011-235] Hence, we defined all the intergenic sequences within 500 bp of the coding region as 'proximal intergenic sequences'. Those intergenic sequences, which lie greater than 500 bp from the coding sequence, were designated as 'deep intergenic sequences'. Concurrently, Neafesy et al has suggested that conserved CpG dinucleotides enriched in proximal intergenic regions might function as regulatory elements.[@b32-ebo-7-2011-235] With these criteria in mind, \~1500 new GC-rich sequences that were identified during the bioinformatics analysis described in this report were pruned down to 151 by screening for proximal intergenic sequences (see [Supplementary Table 1](#s1-ebo-7-2011-235){ref-type="supplementary-material"}).

Immunogenic Proteins are Conserved in P. falciparum and P. reichenowi
---------------------------------------------------------------------

Having shown that 151 sequences that are GC-rich and present in intergenic regions are conserved between *P. falciparum* and *P. reichenowi*, we wished to test our hypothesis that these might be associated with antigenic genes that are found in these two species. As a first step towards this, we tested whether families of antigenic genes found in *P. falciparum* are also present in *P. reichenowi*.

A comparison of the chimpanzee's genetic blue-prints with that of the human genome shows that our closest living relatives share 96 percent of our DNA. Humans and chimps originate from a common ancestor, and scientists believe they diverged some six million years ago.[@b33-ebo-7-2011-235] Interestingly the human malaria parasite *P. falciparum* diverged from the chimpanzee malaria parasite *P. reichenowi* around 5--7 million years ago[@b17-ebo-7-2011-235],[@b34-ebo-7-2011-235] suggesting that the primate parasites may have diverged at the same period when their hosts diverged.

Several studies have shown that *P. falciparum* is most closely related to *P. reichenowi*.[@b20-ebo-7-2011-235],[@b21-ebo-7-2011-235] This is true not only for housekeeping genes but also for genes that encode proteins involved in host-parasite interactions. These include some of the *var* genes that encode the PfEMP family of proteins important for antigenic variation and evasion of the host immune response. Indeed, Trimnell et al[@b22-ebo-7-2011-235] have shown that fragments of the var1CSA and var2CSA genes are conserved between *P. falciparum* and *P. reichenowi* suggesting an ancient origin of some *var* loci. Like *P. falciparum*, *P. reichnowi* is also shown to express key invasion proteins like EBLs and MAEBLs.[@b35-ebo-7-2011-235],[@b36-ebo-7-2011-235] To further test the extent of relatedness of the parasites, an analysis was done for other genes involved in anti-genic variation. Antigenic proteins of *P. falciparum* involved in host pathogen interactions were chosen and BLAST analysis of the genes was performed with *P. reichenowi* contigs (PlasmoDB BLAST server--- blastn). Two genes were chosen at random from each of the PfEMP, *rifin* and *stevor* families of antigenic surface proteins and the *P. yoelii* genome was used for comparison. [Table 1](#t1-ebo-7-2011-235){ref-type="table"} shows the results of this analysis.

Except for the *var* gene PF07_0051 there were fewer than 5 matches to the *P. yoelii* genome with the antigenic genes tested. PF07_0051 showed 27 matches with a best *E* value of 3e--5 indicating that this *var* gene may have weak homology to sequences in the *P. yoelii* genome. This is consistent with the data that there have been no genes showing homology to the *var* gene family in reports on *P. yoelii* genome analysis.[@b8-ebo-7-2011-235] Instead, the *P. yoelii* genome contains a multigene family (*yir*) that shows homology to the *P. vivax vir* multigene family.[@b23-ebo-7-2011-235],[@b24-ebo-7-2011-235] In contrast, 34--194 matches of the *var*, *rifin* and *stevor* genes were obtained by using BLAST against the *P. reichenowi* genome and these matches gave extremely low *E* values (*E* value \< e-140) indicating that the sequences are highly conserved. The high numbers of matches obtained (eg, 194 with a *rifin* gene) indicate that *P. reichenowi* also has three different families of antigenic proteins like *P. falciparum*. Hence the data suggests that the *P. falciparum* genome is more similar to the genome of *P. reichenowi* than *P. yoelii* when antigenic variation genes are analyzed.

Sequences Proximal to var Genes
-------------------------------

Having shown that antigenic variation genes are conserved in *P. falciparum* and *P. reichenowi* and that 151 GC-rich sequences are also conserved in the two genomes, the next question was whether these GC-rich sequences flanked antigenic variation genes.

As mentioned in the previous section, sequestration and rosetting are key determinants of *P. falciparum* pathogenesis and these processes are mediated by the *var* gene family called *Plasmodium falciparum* Erythrocyte Membrane Proteins 1 (PfEMP1). To evade immunity and extend infections, parasites clonally vary the PfEMP1 proteins that are expressed on the surface of the infected red blood cells.[@b37-ebo-7-2011-235] Mechanisms of regulation of *var* genes have been a topic of intense research due to the clinical importance of these genes.[@b38-ebo-7-2011-235],[@b39-ebo-7-2011-235] Expression of *var* genes is regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron.[@b40-ebo-7-2011-235] Upstream promoters of *var* genes fall into four major sequence classes: upsA, upsB, upsC and upsE[@b41-ebo-7-2011-235] of which upsA- upsB- and upsE type *var* genes lie in sub-telomeric regions and upsC-type *var* genes lie in internal clusters. Recent evidence indicates that *var* genes are activated by recruitment of the promoter to a perinuclear site that is permissive for transcription[@b42-ebo-7-2011-235] and also that the PfSIR2 regulator plays a role in *var* gene silencing.[@b43-ebo-7-2011-235],[@b44-ebo-7-2011-235] Recent studies indicate that ncRNAs associate with chromatin and thus regulate the expression of *var* gene family.[@b45-ebo-7-2011-235] Additionally, an upstream ORF can regulate certain *var* genes.[@b29-ebo-7-2011-235]

Interestingly, the BLAST result with *P. reichenowi* showed that 27 of the proximal intergenic GC-rich sequences flank *var* genes (listed in [Table 2](#t2-ebo-7-2011-235){ref-type="table"}). All these sequences lie in the 5′ UTR of the flanking *var* genes and most are less than 20 bp away from the predicted ORF of PfEMP1 proteins. The close proximity of the GC-rich sequences to the *var* ORF led us to wonder whether these sequences might be transcribed either as short RNAs or as part of the *var* mRNA transcripts.

A search of PlasmoDB revealed that the Sugano malaria cDNA library[@b30-ebo-7-2011-235],[@b46-ebo-7-2011-235],[@b47-ebo-7-2011-235] has identified several short transcripts (ESTs AU088275 and AU087013) in the 5′ UTRs of *var* genes. An analysis of the GC-rich sequences that are proximal to *var* genes showed that all except the PfNC4.4var overlap with at least one of the two ESTs AU088275 and AU087013. The two ESTs are transcribed from the same strand as the PfEMP1 mRNA and AU088275 and AU087013 showed alignment with 30 and 16 regions of the *P. falciparum* genome respectively. This bioinformatics study was able to identify 23 out of 30 and 10 out of 16 regions in the case of AU088275 and AU087013 respectively. The GC-rich sequences that were not identified in this study are less conserved compared to *P. reichenowi* and hence did not show up after the BLAST with a cut off of 1e--10. The presence of short transcripts that overlap with the GC-rich sequences identified in this bioinformatics screen suggests that indeed these sequences are transcribed.

PfNC4.4var was the only sequence with no associated ESTs and this sequence lies 190 bases away from the annotated PfEMP1. A BLAST was performed with the sequence of PfNC4.4.var against the genome of *P. falciparum* and we identified 6 matches that were all proximal to PfEMP1 genes. To test whether any short RNAs are associated with the sequence PfNC4.4var we performed Northern analysis on mixed stage asexual parasites using strand-specific probes. These results indicate that the sequence is not expressed in mixed stage asexual parasites (data not shown); perhaps the expression of this sequence is below the limit of detection by Northern analysis or is stage-specific. Alternatively the sequence may function as a DNA regulatory element rather than as RNA or may be involved in translational control of the flanking *var* gene.

The sequences of the ESTs AU088275 and AU087013 were compared with each other and with the sequence PfNC4.4var using ClustalW (<http://www.ebi.ac.uk/clustalw/>). The scores obtained show that the ESTs AU088275 and AU087013 are 68% similar to each other at the sequence level while the sequence PfNC4.4var is quite distinct from either of these ESTs showing 25%--32% sequence similarity in the ClustalW analysis. Further analysis of the ESTs showed that AU088275 and AU087013 are in the 5′ UTRs of *var* genes of the upsB or upsBsh subtypes while sequence PfNC4.4var is found in the 5′ UTRs of 7 *var* genes of the upsC subtype.

Having shown that the GC-rich sequences that flank *var* genes are found in short transcripts, we next asked whether these sequences have the capacity to encode proteins, either as upstream ORFs (uORFs) or as N-terminal extensions of the annotated *var* genes. Indeed, a majority of the GC-rich sequences showed the presence of upstream ORFs (uORFs) ranging in size from minimal ORFs (1 amino acid) to 21 amino acids. Several of the uORFs are found in a majority of the GC-rich regions (pentapeptide MYATI found 20 times) and others are found less frequently (MYQNTTKPCMPRYKPRMHDIM found once).

Interestingly, when all the GC-rich sequences that flank *var* genes were aligned with each other, it was noticed that the most conserved sequences (highlighted in grey with asterisks), encoded the uORF pentapeptide MYATI ([Fig. 1](#f1-ebo-7-2011-235){ref-type="fig"}). In contrast, sequence conservation was poor in the regions surrounding the uORF. This suggests an evolutionary pressure to maintain the uORF encoding sequences indicating these sequences may have functional importance. A sequence alignment between *var*-associated GC-rich sequences of *P. falciparum* and *P. reichenowi* ([Fig. 2](#f2-ebo-7-2011-235){ref-type="fig"}) shows a significant sequence similarity between PfNC12.4var and the homologous region from *P. reichenowi* and the uORF MYATI is conserved between the two species.

uORFs have been shown to play important roles in translational control. For example, a minimal uORF can regulate translation of certain HIV genes.[@b48-ebo-7-2011-235] This minimal ORF (consisting of only a start and a stop codon) overlaps with the start codon of the *vpu* gene and mutating the start and stop codons of this minimal ORF results a reduction of translation of the downstream *env* gene. Upstream AUGs and uORFs in human and rodent genes appear to regulate translation initiation by the ribosome scanning machinery.[@b27-ebo-7-2011-235] Finally, and most pertinently for this work, the presence of uORFs has been shown to regulate the expression of the downstream *var* gene.[@b29-ebo-7-2011-235] We propose that the uORFs identified in this report flank *var* genes at the 5′ regions and may play similar roles in regulation of *var* gene expression.

Sequences Proximal to *rifin* Genes
-----------------------------------

*Rifin* genes constitute the largest multi-gene family in the *P. falciparum* genome with 149 members. Transcription from *rifin* genes is highest at the rings and early trophozoite stages and proteins encoded by these mRNAs are localized to the Maurer's clefts.[@b49-ebo-7-2011-235],[@b50-ebo-7-2011-235] Presence of antibodies against RIFINS in patient sera suggests that these proteins are indeed exposed on the surface of erythrocytes.[@b51-ebo-7-2011-235] More recently, the discovery of a PEXEL/VTS transport signal found in proteins exported from the parasite vacuole to the erythrocyte was observed in RIFIN proteins and is consistent with a potential cell surface localization.[@b52-ebo-7-2011-235],[@b53-ebo-7-2011-235] The function of RIFINS is unknown however these proteins may be involved in cytoadherence. Similar to *var* genes, *rifin* genes are also clonally variable although the mechanisms underlying the two processes appear to be different.

A search of the proximal intergenic GC-rich sequences obtained in our screen of the *P. falciparum* genome shows that 19 sequences flank *rifin* genes. The list of sequences is shown in [Table 3](#t3-ebo-7-2011-235){ref-type="table"}. All the sequences except for one (PfNC10.1rif) lie in the 3′ UTR of *rifin* genes and are 1 to 500 bases away from the stop codon of the *rifin* open reading frame. PfNC10.1rif is located in the 5′ UTR of *rifin* gene PF10_0002w. Four of the GC-rich regions that flank *rifins* are associated with short ESTs (BI816203 and BQ577081) and all the ESTs are transcribed from the same strand as the *rifin* gene. There is a paucity of information regarding regulation of *rifin* gene expression. A recent study has mapped promoter elements that are required for expression of one *rifin* gene (PF11_0009) that is highly expressed in 3D7 parasites. [@b54-ebo-7-2011-235] The promoter elements include two repressor regions that are bound by nuclear proteins expressed at different stages of the parasite life cycle. While 5′ flanking sequences are essential for transcriptional regulation, it is tempting to speculate that events in the 3′ UTRs of *rifin* genes, particularly the GC-rich sequences discovered in this study may play roles in gene regulation.

Conclusion
==========

In conclusion, this report shows that a bioinformatics strategy involving a search for GC-rich intergenic regions that are conserved between *P. falciparum* and *P. reichenowi* can be used to uncover conserved GC-rich sequences proximal to antigenic variation genes. These sequences are transcribed and may also encode short upstream ORFs. It will be of interest to test the functional importance of these sequences in regulation of antigenic variation and clinical disease.

Supplementary materials
=======================

###### 

List of 151 GC-rich sequences proximal to annotated genes identified in P. falciparum.

  S.no   Name of the candidate        Proximal gene and orientation   Proximal gene                                                                  Distance from the proximal gene   GC% and identity
  ------ ---------------------------- ------------------------------- ------------------------------------------------------------------------------ --------------------------------- -------------------
  1      Chr 1: 62341 to 62410                                        RIFIN                                                                          10                                35% and 36/70
  2      Chr 1: 81921 to 81990                                        RIFIN                                                                          8                                 38% and 55/70
  3      Chr 1: 197781 to 197850                                      Ubiquitin carboxyl terminal hydrolase                                          5                                 35% and 62/70
  4      Chr 1: 556971 to 557100                                      PfEMP1                                                                         320                               35% and 126/130
  5      Chr 1: 616621 to 616710                                      PfEMP1                                                                         8                                 38.9% and 33/90
  6      Chr 1: 29631 to 29730                                        PfEMP1                                                                         3                                 37% and 58/100
  7      Chr 1: 503731 to 503800                                      Hypothetical protein                                                                                             35% and 40/70
  8      Chr 2: 25101 to 25230                                        PfEMP1                                                                         2                                 40.8% and 56/130
  9      Chr 2: 32951 to 33020                                        RIFIN                                                                          10                                35% and 36/70
  10     Chr 2: 54331 to 54410                                        STEVOR isoform gam beta                                                        8                                 43.8% and 73/80
  11     Chr 2: 147571 to 147640                                      Hypothetical protein                                                           7                                 37% and 58/70
  12     Chr 2: 165911 to 165990                                      Hypothetical protein                                                           154                               35% and 57/80
  13     Chr 2: 197361 to 197430                                      Hypothetical protein                                                           445                               35% and 66/70
  14     Chr 2: 301801 to 301970                                      Cysteine protease putative                                                     8                                 40.6% and 162/170
  15     Chr 2: 473501 to 473600                                      Protein kinase putative                                                        10                                37% and 93/100
  16     Chr 2: 923651 to 923750                                      PfEMP1                                                                         3                                 42% and 58/100
  17     Chr 3: 8031 to 8160                                          Hypothetical protein                                                           234                               36.2% and 93/130
  18     Chr 3: 8461 to 8540                                          Hypothetical protein                                                                                             35% and 62/80
  19     Chr 3: 10961 to 11050                                        Hypothetical protein                                                           216                               34.4% and 74/90
  20     Chr 3: 33511 to 33640                                        PfEMP1                                                                         1                                 38.5% and 72/130
  21     Chr 3: 443031 to 443120                                      Hypothetical protein                                                           197                               34.4% and 80/90
  22     Chr 3: 540901 to 540980                                      Hypothetical protein                                                                                             35% and 40/50
  23     Chr 3: 686651 to 686720                                      Protein kinase putative                                                        107                               38% and 31/70
  24     Chr 3: 691491 to 691560                                      Protein kinase putative                                                        3                                 35% and 66/70
  25     Chr 3: 1025611 to 1025680                                    Rifin                                                                          12                                35% and 34/70
  26     Chr 3: 1034931 to 1035030                                    Var gene                                                                       7                                 41% and 42/100
  27     Chr 3: 1046441 to 1046510                                    Hypothetical protein                                                           351                               35% and 35/70
  28     Chr 3: 1051191 to 1051280                                    Hypothetical protein                                                           213                               34.4% and 65/90
  29     Chr 4: 35061 to 35150                                        PfEMP1                                                                         3                                 46.7% and 32/90
  30     Chr 4: 67831 to 67940                                        RIFIN                                                                          445                               37.3% and 78/110
  31     Chr 4: 311851 to 311920                                      Hypothetical protein and lysine decarboxylase                                  36 and 298                        35% and 42/70
  32     Chr 4: 336301 to 336410                                      Sexual stage specific precursor and hypothetical protein                       135 and 5                         39.1% and 106/110
  33     Chr 4: 500431 to 500520                                      Hypothetical protein                                                           159                               35.6% and 65/90
  34     Chr 4: 606841 to 606930                                      PfEMP1                                                                         9                                 42.2% and 38/90
  35     Chr 4: 667311 to 667410                                      GTP binding protein                                                            197                               34% and 95/100
  36     Chr 4: 851901 to 851970                                      Hypothetical protein                                                           404                               35% and 54/70
  37     Chr 4: 862591 to 862660                                      CGI141 protein homolog, and hypothetical protein                               322 and 218                       35% and 56/70
  38     Chr 4: 970091 to 970160                                      PfEMP 1                                                                        41                                35% and 34/70
  39     Chr 4: 981221 to 981290                                      PfEMP1                                                                         191                               37% and 36/70
  40     Chr 4: 1064251 to 1064380                                    Hypothetical protein                                                                                             37.7% and 80/130
  41     Chr 4: 1183861 to 1183950                                    PfEMP1                                                                         13                                45.6% and 31/90
  43     Chr 5: 619951 to 620030                                      Hypothetical protein                                                           8                                 38.8% and 56/80
  44     Chr 6: 3401 to 3500                                          PfEMP1                                                                         3                                 42% and 38/100
  45     Chr 6: 296831 to 296920                                      Translation initiation factor IF2                                              38                                34.4% and 77/90
  46     Chr 6: 661791 to 661880                                      Hypothetical proteins                                                          6 and 551                         31.1% and 55/90
  47     Chr 6: 672491 to 672560                                      Hypothetical protein                                                                                             35% and 64/70
  48     Chr 6: 1352101 to 1352170                                    RIFIN                                                                          80                                37% and 50/70
  49     Chr 7: 30531 to 30670                                        PfEMP1                                                                         3                                 37.9% and 81/140
  50     Chr 7: 45441 to 45540                                        RIFIN                                                                          447                               35% and 79/100
  51     Chr 7: 55261 to 55330                                        RIFIN                                                                          1                                 37% and 45/70
  52     Chr 7: 98671 to 98740                                        Hypothetical protein                                                           215                               37% and 70/70
  53     Chr 7: 614461 to 614570                                      PfEMP1                                                                         3                                 40% and 38/110
  54     Chr 7: 644311 to 644440                                      PfEMP1                                                                         8                                 41.5% and 43/130
  55     Chr 7: 1012111 to 1012190                                    Conserved GTP binding protein and cell cycle control protein cwf15 homologue   390 and 108                       32.5% and 44/80
  56     Chr 7: 1145161 to 1145250                                    MAL7_28Sa                                                                      7                                 47.8% and 64/90
  57     Chr 7: 1155801 to 1155890                                    Hypothetical protein                                                           6                                 36.7% and 87/90
  58     Chr 7: 1393981 to 1394050                                    Hypothetical protein                                                           287                               35% and 70/70
  59     Chr 7: 1454751 to 1454820                                    RIFIN                                                                          10                                37% and 47/70
  60     Chr 7: 605971 to 606040                                      PfEMP1                                                                         71                                37% and 35/70
  61     Chr 8: 22251 to 22330                                        PfEMP1                                                                         39                                41.3% and 41/80
  62     Chr 8: 98871 to 99000                                        MAL8b_28s rRNA                                                                 176                               36.2% and 117/130
  63     Chr 8: 99751 to 99850                                        PF08_tmp2                                                                      164                               36% and 98/100
  64     Chr 8: 187771 to 187870                                      Hypothetical protein                                                                                             31% and 93/100
  65     Chr 8: 233921 to 233990                                      Tubulin gamma chain                                                            45                                35% and 66/70
  66     Chr 8: 441381 to 441450                                      PfEMP1                                                                         80                                38% and 34/70
  67     Chr 8: 1289051 to 1289130                                    PF08_tmp1 r RNA and putative senescence associated protein                     225 and 129                       50% and 53/80
  68     Chr 8: 1289821 to 1289940                                    Senescence associated protein                                                  163                               40% and 116/120
  69     Chr 8: 1290151 to 1290250                                    Senescence associated protein                                                  493                               37% and 96/100
  70     Chr 8: 1399241 to 1399340                                    PfEMP1                                                                         7                                 38% and 38/100
  71     Chr 8: 1410561 to 1410640                                    Hypothetical protein                                                                                             35% and 56/80
  72     Chr 8: 1412661 to 1412770                                    Hypothetical protein                                                           10                                38.2% and 52/110
  73     Chr 9: 19931 to 20070                                        PfEMP1                                                                         10                                40.7% and 92/140
  74     Chr 9: 42361 to 42460                                        RIFIN                                                                          449                               34% and 80/100
  75     Chr 9: 369131 to 369220                                      Formylmethionine deformylase                                                   349                               31.1% and 55/90
  76     Chr 9: 406351 to 406460                                      Transporter protein and hypothetical protein                                   74 and 54                         33.6% and 108/110
  77     Chr 9: 632261 to 632330                                      Hypothetical protein                                                           63                                35% and 58/70
  78     Chr 9: 749991 to 750080                                      Large ribosomal subunit protein L3, prokaryotic (50S)like                      115                               32.2% and 88/90
  79     Chr 9: 757341 to 757430                                      Hypothetical protein                                                                                             33.3% and 50/90
  80     Chr 9: 907861 to 907930                                      Hypothetical protein                                                                                             37% and 64/90
  81     Chr 9: 1092431 to 1092510                                    NAD synthase and Hypothetical protein                                          11 and 324                        32.5% and 75/80
  82     Chr 9: 1107301 to 1107400                                    Hypothetical protein                                                           2                                 44% and 100/100
  83     Chr 9: 1130251 to 1130370                                    Cytochrome c oxidase subunit,                                                  321                               32.5% and 103/120
  84     Chr 9: 1283801 to 1283870                                    Hypothetical protein                                                           359                               37% and 70/70
  85     Chr 9: 1291101 to 1291170                                    Hypothetical protein                                                           84                                35% and 54/70
  86     Chr 9: 1293991 to 1294060                                    Peptide release factor and DHHC type zinc finger protein                       353 and 199                       37% and 62/70
  87     Chr 9: 1314241 to 1314350                                    mRN A processing protein and Hypothetical protein                              526 and 192                       35.5% and 101/110
  88     Chr 9: 1479191 to 1479290                                    RIFIN                                                                          467                               35% and 81/100
  89     Chr 9: 1503331 to 1503430                                    PfEMP1                                                                         7                                 37% and 38/100
  90     Chr 10: 28351 to 28490                                       PfEMP1                                                                         1                                 36.4% and 76/100
  91     Chr 10: 39021 to 39090                                       RIFIN                                                                          17                                35.7% and 89/100
  92     Chr 10: 47981 to 48050                                       RIFIN                                                                          3                                 35.7% and 88/100
  93     Chr 10: 125441 to 125510                                     Hypothetical protein                                                           430                               37.1% and 57/70
  94     Chr 10: 274111 to 274200                                     Hypothetical protein                                                           182                               37.8% and 87/90
  95     Chr 10: 401521 to 401590                                     Hypothetical protein                                                                                             37.1% and 54/70
  96     Chr 10: 694111 to 694200                                     Hypothetical protein                                                           10                                35.6% and 50/90
  97     Chr 10: 886941 to 887040                                     Hypothetical proteins                                                          4 and 347                         34% and 98/100
  98     Chr 10: 960765 to 960854                                     Hypothetical protein                                                                                             32.2% and 88/90
  99     Chr 10: 1162615 to 1162694                                   Hypothetical protein                                                                                             35% and 79/80
  100    Chr 10: 1211885 to 1211964                                   Hypothetical protein                                                           80                                36.3% and 77/80
  101    Chr 10: 1231655 to 1231784                                   Hypothetical protein                                                           19                                33.8% and 100/130
  102    Chr 10: 1623881 to 1623950                                   RIFIN                                                                          22                                35.7% and 98/100
  103    Chr 11: 5321 to 5460                                         Hypothetical protein                                                           388                               37.1% and 115/140
  104    Chr 11: 5631 to 5730                                         Hypothetical protein                                                           118                               34% and 66/100
  105    Chr 11: 6141 to 6220                                         Hypothetical protein                                                           51                                35% and 65/80
  106    Chr 11: 6311 to 6420                                         Hypothetical protein                                                           221 and 401                       35.5% and 73/110
  107    Chr 11: 6581 to 6760                                         Hypothetical proteins                                                          491 and 61                        34.4% and 149/180
  108    Chr 11: 6901 to 7110                                         Hypothetical protein                                                           71                                36.2% and 145/210
  109    Chr 11: 7271 to 7420                                         Hypothetical protein                                                           232 and 340                       41.3% and 106/150
  110    Chr 11: 7501 to 7600                                         Hypothetical protein                                                           462 and 180                       33% and 57/100
  111    Chr 11: 7941 to 8210                                         Hypothetical protein                                                           61                                40% and 119/270
  112    Chr 11: 8411 to 8720                                         Hypothetical protein                                                           262                               34.2% and 251/310
  113    Chr 11: 18451 to 18530                                       Hypothetical protein                                                           17                                35% and 69/80
  114    Chr 11: 24021 to 24150                                       PfEMP1                                                                         10                                49% and 67/120
  115    Chr 11: 150597 to 150706                                     Hypothetical protein                                                           103                               36.4% and 107/110
  116    Chr 11: 151007 to 151126                                     Hypothetical protein                                                           105                               35% and 118/120
  117    Chr 11: 317947 to 318026                                     Hypothetical protein                                                           99                                32.5% and 80/80
  118    Chr 11: 347207 to 347276                                     Hypothetical protein                                                           240                               37.1% and 69/70
  119    Chr 11: 569106 to 569175                                     Hypothetical protein                                                           56 and 220                        35.7% and 69/70
  120    Chr 11: 796606 to 796695                                     Hypothetical protein                                                           173                               35.6% and 90/90
  121    Chr 11: 1395814 to 1395883                                   Hypothetical protein                                                                                             36.8% and 66/70
  122    Chr 11: 1417434 to 1417503                                   Hypothetical protein                                                           453                               35.7% and 66/70
  123    Chr 11: 1527984 to 1528073                                   Hypothetical protein                                                                                             35.6% and 81/90
  124    Chr 11: 1663894 to 1664013                                   Hypothetical protein                                                           216                               30.8% and 117/120
  125    Chr 11: 1918214 to 1918333                                   Hypothetical protein                                                           217 and 74                        33.3% and 112/120
  126    Chr 11: 1927134 to 1927213                                   Hypothetical protein                                                           5 and 255                         36.3% and 44/80
  127    Chr 11: 1929634 to 1929743                                   Hypothetical protein                                                           58                                38.2% and 78/110
  128    Chr 11: 1929974 to 1930053                                   Hypothetical protein                                                           282                               36.3% and 58/80
  129    Chr 11: 2010214 to 2010293                                   RIFIN                                                                          4                                 40% and 97/100
  130    Chr 12: 32601 to 32670                                       PfEMP1                                                                         33                                37.1% and 41/70
  131    Chr 12: 43711 to 43790                                       RIFIN                                                                          10                                33.8% and 92/100
  132    Chr 12: 774191 to 774300                                     PfEMP1                                                                         1                                 38.2% and 53/110
  133    Chr 12: 1360341 to 1360430                                   Hypothetical protein                                                           190                               34.4% and 54/90
  134    Chr 12: 1404951 to 1405020                                   Hypothetical protein                                                           149                               37.1% and 67/70
  135    Chr 12: 1529361 to 1529430                                   Hypothetical protein                                                           379                               37.1% and 70/70
  136    Chr 12: 1704411 to 1704490                                   PfEMP1                                                                         10                                46.3% and 36/80
  137    Chr 12: 1739561 to 1739630                                   PfEMP1                                                                                                           37.5% and 35/70
  138    Chr 12: 2239401 to 2239480                                   RIFIN                                                                          1                                 35% and 87/100
  139    Chr 12: 2248951 to 2249040                                   PfEMP1                                                                         6                                 45.6% and 56/90
  140    Chr 13: 30631 to 30700                                       RIFIN                                                                          8                                 37.1% and 94/100
  141    Chr 13: 53591 to 53670                                       RIFIN                                                                          500                               40% and 95/100
  142    Chr 13: 977431 to 977520                                     Aspartyl (acid) protease, putative                                             55                                38.9% and 82/90
  143    Chr 13: 2517471 to 2517550                                   Hypothetical protein                                                           123                               33.8% and 79/80
  144    Chr 13: 2791651 to 2791760                                   Hypothetical protein conserved                                                 227 and 76                        30.9% and 102/110
  145    Chr 13: 2799331 to 2799400                                   MAL13_5.8SrRNA rRNA                                                            311                               35.7% and 57/70
  146    Chr 14: 141091 to 141160                                     Hypothetical protein and acid phosphatase                                      206 and 250                       37.1% and 62/70
  147    Chr 14: 472871 to 472940                                     GTP-binding protein, putative                                                  2                                 35.7% and 59/70
  148    Chr 14: 989170 to 989279                                     DNA directed DNA polymerase                                                    82                                35.5% and 103/110
  149    Chr 14: 1086373 to 1086442                                   Hypothetical protein                                                           380                               35.7% and 69/70
  150    Chr 14: 1213632 to 1213711                                   Hypothetical protein                                                           177                               35% and 80/80
  151    Chr 14: 1540333 to 1540412                                   Translocation protein sec62, putative                                          170                               35% and 77/80
  152    Chr 14: 2247864 to 2247933                                   Protein phosphatase 2C, putative                                               349                               35.7% and 69/70
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![Sequence alignment of proximal upstream regions of upsB var genes.\
**Notes:** The box shows that conserved GC-rich sequences contain the putative upstream ORF MYATI. Grey highlights show-conserved sequences, indicating that sequences flanking the putative uORF are less conserved than the regions encoding the uORF. The annotated start codon is highlighted in grey.](ebo-7-2011-235f1){#f1-ebo-7-2011-235}

![BLAST result of PfNC12.4var against the *Plasmodium reichenowi* genome.\
**Note:** The regions of conservation are shown with stars and the uORF is highlighted in grey.](ebo-7-2011-235f2){#f2-ebo-7-2011-235}

###### 

BLAST analysis of antigenic proteins.

  Gene ID and the gene product   No of hits with *P. yoelii*   *E* value of best hit with *P. yoelii*   No of hits with *P. reichenowi*   *E* value of best hit with *P. reichenowi*   Best hit with *P. reichenowi*
  ------------------------------ ----------------------------- ---------------------------------------- --------------------------------- -------------------------------------------- -------------------------------
  MAL13P1.1 PfEMP1               2                             0.027                                    109                               2e--87                                       Pr_3502696.c000023469.Contig1
  PF07_0051 PfEMP1               27                            3e--5                                    107                               7e--54                                       Pr_3502696.c000023041.Contig1
  MAL13P1.2 RIFIN                2                             0.017                                    194                               e-128                                        Pr_3502696.c000027339.Contig1
  PFF0850c RIFIN                 0                             --                                       37                                2e--95                                       Pr_3502696.c000023726.Contig1
  MAL13P1.505 STEVOR             1                             0.015                                    35                                e-140                                        Pr_3502696.c000023791.Contig1
  PFI0045c STEVOR                4                             0.014                                    34                                e-136                                        Pr_3502696.c000023791.Contig1

**Note:** Two members of the PfEMP, rifin and stevor families were chosen arbitrarily from the *P. falciparum* genome and BLAST was performed against the genomes of *Plasmodium yoelii* and *Plasmodium reichenowi*.

###### 

Conserved GC rich sequence associated with *var* genes.

  Candidate     Location                     PfEMP1 Associated   GC%    Identity   Associated ESTs
  ------------- ---------------------------- ------------------- ------ ---------- -----------------------
  PfNC1.1var    Chr 1: 29631 to 29730        PFA0005w            37     58/100     AU088275
  PfNC1.2var    Chr 1: 616621 to 616710      PFA0765c            38.9   33/90      AU088275 and AU087013
  PfNC2.1var    Chr 2: 25101 to 25230        PFB0010w            40.8   56/130     AU087013 and AU088275
  PfNC2.2var    Chr 2: 923651 to 923750      PFB1055c            42     58/100     AU087013 and AU088275
  PfNC3.1var    Chr 3: 33511 to 33640        PFC0005w            38.5   72/130     AU088275
  PfNC3.2var    Chr 3: 1034931 to 1035030    PFC1120c            41     42/100     AU088275
  PfNC4.1var    Chr 4: 35061 to 35150        PFD0005w            46.7   32/90      AU088275
  PfNC4.2var    Chr 4: 606841 to 606930      PFD0635c            42.2   38/90      AU088275
  PfNC4.3var    Chr 4: 970091 to 970160      PFD1005c            35     34/70      AU088275
  PfNC4.4var    Chr 4: 981221 to 981290      PFD1015c            37     36/70      --
  PfNC4.5var    Chr 4: 1183861 to 1183950    PFD1245c            45.6   31/90      AU088275
  PfNC6var      Chr 6: 3401 to 3500          PFF0010w            42     38/100     AU088275
  PfNC7.1var    Chr 7: 30531 to 30670        MAL7P1.212          37.9   81/140     AU088275 and AU087013
  PfNC7.2var    Chr 7: 605971 to 606040      MAL7P1.50           37     35/70      AU088275
  PfNC7.3var    Chr 7: 614461 to 614570      PF07_0050           40     38/110     AU088275
  PfNC7.4var    Chr 7: 644311 to 644440      MAL7P1.55           41.5   43/130     AU087013
  PfNC8.1var    Chr 8: 22251 to 22330        PF08_0142           41.3   41/80      AU087013
  PfNC8.2var    Chr 8: 441381 to 441450      PF08_0106           38     34/70      AU087013
  PfNC8.3var    Chr 8: 1399241 to 1399340    MAL8P1.220          38     38/100     AU088275 and AU087013
  PfNC9.1var    Chr 9: 19931 to 20070        PFI0005w            40.7   92/140     AU088275
  PfNC9.2var    Chr 9: 1503331 to 1503430    PFI1830c            37     38/100     AU088275
  PfNC10var     Chr 10: 28351 to 28490       PF10_0001           36.4   76/100     AU088275
  PfNC11var     Chr 11: 24021 to 24150       PF11_0007           40     67/130     AU088275
  PfNC12.1var   Chr 12: 32601 to 32670       PFL0020w            37.1   41/70      AU088275
  PfNC12.2var   Chr 12: 774191 to 774300     PFL0935c            38.2   53/110     AU088275 and AU087013
  PfNC12.3var   Chr 12: 1704411 to 1704490   PFL1955w            46.3   36/80      AU088275 and AU087013
  PfNC12.4var   Chr 12: 2248951 to 2249040   PFL2665c            45.6   56/90      AU088275

**Note:** All candidates are found in the 5′ UTRs of *var* genes and are within 150 bases of the start codon.

###### 

Conserved GC rich regions associated with *rifin* genes.

  S.no          Candidate                    Associated RIFIN   GC%     Identity   Associated ESTs
  ------------- ---------------------------- ------------------ ------- ---------- -----------------
  PfNC1.1rif    Chr 1: 62341 to 62410        PFA0045c           35%     36/70      --
  PfNC1.2rif    Chr 1: 81921 to 81990        PFA0080c           38%     55/70      --
  PfNC2rif      Chr 2: 32951 to 33020        PFB0015c           35%     36/70      --
  PfNC3rif      Chr 3: 1025611 to 1025680    PFC1115w           35%     34/70      BI816203
  PfNC4rif      Chr 4: 67831 to 67940        PFD0025w           37.3%   78/110     --
  PfNC6rif      Chr 6: 1352101 to 1352170    PFF1575w           37%     50/70      --
  PfNC7.1rif    Chr 7: 45441 to 45540        MAL7P1.215         35%     79/100     --
  PfNC7.2rif    Chr 7: 55261 to 55330        MAL7P1.217         37%     45/70      BQ577081
  PfNC7.3rif    Chr 7: 1454751 to 1454820    PF07_0134          37%     47/70      --
  PfNC9.1rif    Chr 9: 42361 to 42460        PFI0025c           34%     80/100     --
  PfNC9.2rif    Chr 9: 1479191 to 1479290    PFI1810w           35%     81/100     --
  PfNC10.1rif   Chr 10: 39021 to 39090       PF10_0002w         35.7%   89/100     --
  PfNC10.2rif   Chr 10: 47981 to 48050       PF10_0005          35.7%   88/100     --
  PfNC10.3rif   Chr 10: 1623881 to 1623950   PF10_0398          35.7%   98/100     --
  PfNC12.1rif   Chr 12: 43711 to 43790       PFL0025c           33.8%   92/100     BQ577081
  PfNC12.2rif   Chr 12: 2239401 to 2239480   PFL2660w           35%     87/100     --
  PfNC13.1rif   Chr 13: 30631 to 30700       MAL13P1.2          37.1%   94/100     BQ577081
  PfNC13.2rif   Chr 13: 53591 to 53670       PF13_0006          40%     95/100     --

**Note:** All candidates are found in the 3′ UTRs of *rifin* genes.
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